CIK 0001831868 · <br>Emerging growth company
SeaStar Medical Holding Corp
Sign in to watch- Ticker
- ICU
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 853681132
- Phone
- 844-427-8100
- Business address
- 3513 BRIGHTON BLVD, SUITE 410, DENVER, CO, 80216
- Former names
- LMF Acquisition Opportunities Inc
Securities
- ICU Common Stock Nasdaq
- ICUCW Warrant Nasdaq
- Open-market buys, last 90 days
- $2,453
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$2,453. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-08-15 | Schlorff Eric Chief Executive Officer | Grant or award 10b5-1 | +21,176 | 703,575 | ||
| 2023-08-15 | Baron Caryl Interim CFO | Grant or award | +2,031 | 97,022 | ||
| 2023-06-23 | Schlorff Eric Chief Executive Officer | Grant or award | +417,386 | 682,399 | ||
| 2023-06-09 | Baron Caryl Interim CFO | Grant or award | +56,869 | 110,061 | ||
| 2023-06-09 | Baron Caryl Interim CFO | Shares withheld for taxes | −15,070 | $0.53 | $8K | 94,991 |
| 2023-05-30 | Chung Kevin Chief Medical Officer | Purchase | +5,093 | $0.47 | $2K | 60,675 |
| 2023-05-30 | Chung Kevin Chief Medical Officer | Purchase | +4,000 | $0.48 | $2K | 64,675 |
| 2023-05-30 | Chung Kevin Chief Medical Officer | Purchase | +2,300 | $0.48 | $1K | 66,975 |
| 2023-05-30 | Chung Kevin Chief Medical Officer | Purchase | +1,150 | $0.48 | $546 | 68,125 |
| 2023-05-25 | Russell Richard D. Director | Purchase | +20,000 | $0.50 | $10K | 27,978 |
| 2023-05-18 | Chung Kevin Chief Medical Officer | Purchase | +7,500 | $0.70 | $5K | 55,582 |
| 2023-04-06 | Rodgers Bruce M. Director | Grant or award | +7,978 | 7,978 | ||
| 2023-04-06 | Rodgers Bruce M. Director | Grant or award · Stock Option (Right to Buy) | +11,967 | 11,967 | ||
| 2023-04-06 | Baron Caryl Interim CFO | Grant or award | +11,080 | 53,192 | ||
| 2023-04-06 | Baron Caryl Interim CFO | Grant or award · Stock Option (Right to Buy) | +16,621 | 16,621 | ||
| 2023-04-06 | Schlorff Eric Chief Executive Officer | Grant or award | +66,483 | 265,013 | ||
| 2023-04-06 | Schlorff Eric Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +99,724 | 99,724 | ||
| 2023-04-06 | Collins Allan Director | Grant or award | +7,978 | 16,400 | ||
| 2023-04-06 | Collins Allan Director | Grant or award · Stock Option (Right to Buy) | +11,967 | 11,967 | ||
| 2023-04-06 | Van Heel Kenneth Director | Grant or award | +7,978 | 16,400 |
Page 5 of 7 · 136 trades